Patients And Payers, Not Products, Are Kings In The New Pharma Model
Executive Summary
Embracing the threat from new technology providers is the only way to prosper in the 21st century healthcare system. A structure where payers are looking for health outcomes, patients are empowered and the product is no longer the sole bearer of the crown, a new report from Datamonitor Healthcare says.
You may also be interested in...
Coming Of Age: Pharma’s Influencer Marketing Matures
Influencer marketing has emerged as a potent tool for many industries and is a sector set to be worth $22bn in its own right by 2025.
Building Out A Blockbuster Franchise: AstraZeneca’s Growth Plans For US Lung Cancer Therapy
Arun Krishna reveals portfolio plans for best-selling therapy Tagrisso, and its other activities to prevent, screen and diagnose lung cancer faster.
Investment And Acquisition In Rare Diseases
In Vivo talks to investors, analysts and companies in rare disease about the challenges they face to innovate and to grow.